0001209191-16-148734.txt : 20161107 0001209191-16-148734.hdr.sgml : 20161107 20161107185650 ACCESSION NUMBER: 0001209191-16-148734 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20161103 FILED AS OF DATE: 20161107 DATE AS OF CHANGE: 20161107 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALBIREO PHARMA, INC. CENTRAL INDEX KEY: 0001322505 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 MILK STREET STREET 2: 16TH FLOOR CITY: BOSTON STATE: MA ZIP: 02109 BUSINESS PHONE: 857-415-4774 MAIL ADDRESS: STREET 1: 50 MILK STREET STREET 2: 16TH FLOOR CITY: BOSTON STATE: MA ZIP: 02109 FORMER COMPANY: FORMER CONFORMED NAME: Biodel Inc DATE OF NAME CHANGE: 20050331 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ASTRAZENECA AB CENTRAL INDEX KEY: 0000928966 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33451 FILM NUMBER: 161979565 BUSINESS ADDRESS: STREET 1: V?STRA M?LAREHAMNEN 9 CITY: S?DERT?LJE STATE: V7 ZIP: SE-151 85 BUSINESS PHONE: 0044 (0) 20 7604 800 MAIL ADDRESS: STREET 1: V?STRA M?LAREHAMNEN 9 CITY: S?DERT?LJE STATE: V7 ZIP: SE-151 85 FORMER NAME: FORMER CONFORMED NAME: ASTRA AB DATE OF NAME CHANGE: 19981116 FORMER NAME: FORMER CONFORMED NAME: ASTRA AKTIEBOLAG DATE OF NAME CHANGE: 19960718 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ASTRAZENECA PLC CENTRAL INDEX KEY: 0000901832 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33451 FILM NUMBER: 161979566 BUSINESS ADDRESS: STREET 1: 2 KINGDOM STREET - LEGAL DEPARTMENT CITY: LONDON STATE: X0 ZIP: W2 6BD BUSINESS PHONE: 011 44 20 7304 5000 MAIL ADDRESS: STREET 1: 2 KINGDOM STREET - LEGAL DEPARTMENT CITY: LONDON STATE: X0 ZIP: W2 6BD FORMER NAME: FORMER CONFORMED NAME: ZENECA GROUP PLC DATE OF NAME CHANGE: 19930422 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2016-11-03 0 0001322505 ALBIREO PHARMA, INC. ALBO 0000901832 ASTRAZENECA PLC 2 KINGDOM STREET LONDON X0 W2 6BD UNITED KINGDOM 0 0 1 0 0000928966 ASTRAZENECA AB C/O ASTRAZENECA PLC 2 KINGDOM STREET LONDON X0 W2 6BD UNITED KINGDOM 0 0 1 0 Common Stock 1008141 I Held by AstraZeneca AB Represents shares of common stock of Albireo Pharma, Inc. (the "Issuer"), formerly known as Biodel Inc., issued in the share exchange transaction that was completed on November 3, 2016 pursuant to an Amended and Restated Share Exchange Agreement, dated as of July 13, 2016, by and among Biodel Inc., Albireo Limited ("Albireo") and the holders of Albireo shares and notes convertible into Albireo shares. AstraZeneca AB is a wholly-owned subsidiary of AstraZeneca PLC. AstraZeneca PLC may be deemed to beneficially own the shares held by AstraZeneca AB, but disclaims beneficial ownership except to the extent of its pecuniary interest therein, if any. Exhibit 24.1 - Power of Attorney of AstraZeneca PLC, Exhibit 24.2 - Power of Attorney of AstraZeneca AB /s/ Peter A. Zorn, Attorney-in-fact for AstraZeneca PLC 2016-11-07 /s/ Peter A. Zorn, Attorney-in-fact for AstraZeneca AB 2016-11-07 EX-24.1 2 attachment1.htm EX-24.1 DOCUMENT 
Exhibit 24.1
POWER OF ATTORNEY


       Know all by these presents, that the undersigned hereby constitutes and
appoints Thomas A. Shea and Peter A. Zorn, each of Albireo Pharma, Inc. (the
"Company"), and Megan Gates, John Condon, Mark Higgins and Allyson Wilkinson,
each of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., signing singly,
with full power of substitution, the undersigned's true and lawful
attorney-in-fact to:
(1) 	execute for and on behalf of the undersigned, in the undersigned's capacity
as an officer, director and/or 10% stockholder of the Company, Forms 3, 4 and 5
in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the
rules thereunder; and

	(2)	do and perform any and all acts for and on behalf of the undersigned which
may be necessary or desirable to complete and execute any such Form 3, 4 or 5
and timely file such form with the United States Securities and Exchange
Commission and any stock exchange or similar authority, it being understood that
the documents executed by such attorney-in-fact, on behalf of the undersigned
pursuant to this Power of Attorney, shall be in such form and shall contain such
terms and conditions as such attorney-in-fact may approve in such
attorney-in-fact's discretion.

	The undersigned hereby grants to each such attorney-in-fact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary, or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might or
could do if personally present, with full power of substitution or revocation,
hereby ratifying and confirming all that such attorney-in-fact, or such
attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be
done by virtue of this power of attorney and the rights and powers herein
granted.  The undersigned acknowledges that the foregoing attorneys-in-fact, in
serving in such capacity at the request of the undersigned, is not assuming, nor
is the Company assuming, any of the undersigned's responsibilities to comply
with Section 16 of the Securities Exchange Act of 1934.

	This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4 and 5 with respect to the
undersigned's holdings of and transactions in securities issued by the Company,
unless earlier revoked by the undersigned in a signed writing delivered to the
foregoing attorneys-in-fact.

	IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed this 10th day of October, 2016.


ASTRAZENECA PLC


By: /s/ Adrian C N Kemp
Name: Adrian C N Kemp
Title: Company Secretary
EX-24.2 3 attachment2.htm EX-24.2 DOCUMENT 
Exhibit 24.2
POWER OF ATTORNEY


       Know all by these presents, that the undersigned hereby constitutes and
appoints Thomas A. Shea and Peter A. Zorn, each of Albireo Pharma, Inc. (the
"Company"), and Megan Gates, John Condon, Mark Higgins and Allyson Wilkinson,
each of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., signing singly,
with full power of substitution, the undersigned's true and lawful
attorney-in-fact to:
(1) 	execute for and on behalf of the undersigned, in the undersigned's capacity
as an officer, director and/or 10% stockholder of the Company, Forms 3, 4 and 5
in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the
rules thereunder; and

	(2)	do and perform any and all acts for and on behalf of the undersigned which
may be necessary or desirable to complete and execute any such Form 3, 4 or 5
and timely file such form with the United States Securities and Exchange
Commission and any stock exchange or similar authority, it being understood that
the documents executed by such attorney-in-fact, on behalf of the undersigned
pursuant to this Power of Attorney, shall be in such form and shall contain such
terms and conditions as such attorney-in-fact may approve in such
attorney-in-fact's discretion.

	The undersigned hereby grants to each such attorney-in-fact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary, or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might or
could do if personally present, with full power of substitution or revocation,
hereby ratifying and confirming all that such attorney-in-fact, or such
attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be
done by virtue of this power of attorney and the rights and powers herein
granted.  The undersigned acknowledges that the foregoing attorneys-in-fact, in
serving in such capacity at the request of the undersigned, is not assuming, nor
is the Company assuming, any of the undersigned's responsibilities to comply
with Section 16 of the Securities Exchange Act of 1934.

	This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4 and 5 with respect to the
undersigned's holdings of and transactions in securities issued by the Company,
unless earlier revoked by the undersigned in a signed writing delivered to the
foregoing attorneys-in-fact.

	IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed this 11th day of October, 2016.


ASTRAZENECA AB

By: /s/ Jan-Olof Jacke
Name: Jan-Olof Jacke
Title: President